Cited by

• iPS-Cell Technology and the Problem of Genetic Instability-Can It Ever Be Safe for Clinical Use?

  Attwood SW, Edel MJ. Attwood SW, et al. J Clin Med. 2019 Feb 28;8(3):288. doi: 10.3390/jcm8030288. J Clin Med. 2019. PMID: 30823421 Free PMC article. Review.
• Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents.

  Gavriilaki M, Sakellari I, Gavriilaki E, Kimiskidis VK, Anagnostopoulos A. Gavriilaki M, et al. Stem Cells Int. 2019 Jun 24;2019:5840286. doi: 10.1155/2019/5840286. eCollection 2019. Stem Cells Int. 2019. PMID: 31341484 Free PMC article. Review.
• Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine.

  Harris AR, Walker MJ, Gilbert F. Harris AR, et al. BMC Med. 2022 Dec 27;20(1):499. doi: 10.1186/s12916-022-02710-9. BMC Med. 2022. PMID: 36575403 Free PMC article.
• Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.

  Mazzini L, Gelati M, Profico DC, Sorarù G, Ferrari D, Copetti M, Muzi G, Ricciolini C, Carletti S, Giorgi C, Spera C, Frondizi D, Masiero S, Stecco A, Cisari C, Bersano E, De Marchi F, Sarnelli MF, Querin G, Cantello R, Petruzzelli F, Maglione A, Zalfa C, Binda E, Visioli A, Trombetta D, Torres B, Bernardini L, Gaiani A, Massara M, Paolucci S, Boulis NM, Vescovi AL; ALS-NSCs Trial Study Group. Mazzini L, et al. Stem Cells Transl Med. 2019 Sep;8(9):887-897. doi: 10.1002/sctm.18-0154. Epub 2019 May 18. Stem Cells Transl Med. 2019. PMID: 31104357 Free PMC article. Clinical Trial.
• Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis.

  Abati E, Bresolin N, Comi G, Corti S. Abati E, et al. Mol Neurobiol. 2019 Oct;56(10):6703-6715. doi: 10.1007/s12035-019-1554-x. Epub 2019 Mar 26. Mol Neurobiol. 2019. PMID: 30911936 Review.